The activation of the CTNNB1 pathway has been previously linked to breast cancer progression, and thus our data corroborates the importance of this network [62] and suggests an additional therapeutic opportunity to intervene in metastasis establishment and progression. Here, CTNNB1 is linked to breast cancer.